FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.3  |  FHIR Version n/a  User: [n/a]

703840003: Aflibercept (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2014. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3009274019 Aflibercept en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3009606010 Aflibercept (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4850391000005116 aflibercept da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Aflibercept Is a Fusion protein (substance) true Inferred relationship Some
Aflibercept Is a Angiogenesis inhibitor true Inferred relationship Some
Aflibercept This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Angiogenesis inhibitor (disposition) true Inferred relationship Some
Aflibercept Is a Antineoplastic agent (substance) true Inferred relationship Some
Aflibercept This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Vascular endothelial growth factor receptor antagonist (disposition) true Inferred relationship Some
Aflibercept Is a Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing aflibercept (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Aflibercept Inferred relationship Some 1
Aflibercept-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Aflibercept Inferred relationship Some 1
Aflibercept only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Aflibercept Inferred relationship Some 1
Product containing only aflibercept in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Aflibercept Inferred relationship Some 1
Product containing precisely aflibercept 40 milligram/1 milliliter conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Aflibercept Inferred relationship Some 1
Product containing precisely aflibercept 40 milligram/1 milliliter conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Aflibercept Inferred relationship Some 1

This concept is not in any reference sets

Back to Start